BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2723926)

  • 1. Effects of pyran copolymer on host resistance of mice to Plasmodium yoelii.
    Krishna VR; Fouant MM; Bradley SG
    J Parasitol; 1989 Jun; 75(3):405-10. PubMed ID: 2723926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes.
    Sayles PC; Wassom DL
    J Immunol; 1988 Jul; 141(1):241-8. PubMed ID: 3379305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
    Rao VS; Mitchell MS
    J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition and enhancement of Friend leukemia virus by pyran copolymer.
    Schuller GB; Morahan PS; Snodgrass M
    Cancer Res; 1975 Aug; 35(8):1915-20. PubMed ID: 1149015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide enhances both primary and secondary host resistances to Listeria monocytogenes infection by a neutrophil-related mechanism in female B6C3F1 mice.
    Guo TL; Chi RP; Karrow NA; Zhang LX; Pruett SB; Germolec DR; White KL
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):244-54. PubMed ID: 15921716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the pharmacokinetics of MVE-2 to enhance its effects on host resistance.
    Shopp GM; Munson AE
    Prog Clin Biol Res; 1984; 161():501-9. PubMed ID: 6483901
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of hepatic inflammatory response by Plasmodium berghei sporozoites protects BALB/c mice against challenge with Plasmodium yoelii sporozoites.
    Vanderberg JP; Khan ZM; Stewart MJ
    J Parasitol; 1993 Oct; 79(5):763-7. PubMed ID: 8410550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity.
    Puccetti P; Santoni A; Riccardi C; Holden HT; Herberman RB
    Int J Cancer; 1979 Dec; 24(6):819-25. PubMed ID: 232496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
    Schultz RM; Woods WA; Mohr SJ; Chirigos MA
    Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide modulation of the immune response in female B6C3F1 mice: a host resistance study.
    Karrow NA; Guo TL; Zhang LX; McCay JA; Musgrove DL; Peachee VL; Germolec DR; White KL
    Int Immunopharmacol; 2003 Oct; 3(10-11):1447-56. PubMed ID: 12946441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and serum involvement in protection against Friend leukemia virus.
    Schuller GB; Morahan PS
    Cancer Res; 1977 Nov; 37(11):4064-9. PubMed ID: 908040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and biological adjuvants capable of potentiating tumor cell vaccine.
    Chirigos MA; Stylos WA; Schultz RM; Fullen JR
    Cancer Res; 1978 Apr; 38(4):1085-91. PubMed ID: 416906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific potentiation of L1210 vaccine by pyran copolymer.
    Mohr SJ; Chirigos MA; Smith GT; Fuhrman FS
    Cancer Res; 1976 Jun; 36(6):2035-9. PubMed ID: 1268855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
    Adams DO; Johnson WJ; Marino PA; Dean JH
    Cancer Res; 1983 Aug; 43(8):3633-7. PubMed ID: 6861134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immunization against murine malaria with an IgG3 monoclonal antibody.
    Majarian WR; Daly TM; Weidanz WP; Long CA
    J Immunol; 1984 Jun; 132(6):3131-7. PubMed ID: 6725950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyran copolymer: effect of molecular weight on stem cell mobilization in mice.
    Zander AR; Spitzer G; Verma DS; Ginzbarg S; Dicke KA
    Biomedicine; 1980 May; 33(3):69-72. PubMed ID: 7448325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium yoelii: assessment of production and role of nitric oxide during the early stages of infection in susceptible and resistant mice.
    Wang QH; Liu YJ; Liu J; Chen G; Zheng W; Wang JC; Cao YM
    Exp Parasitol; 2009 Mar; 121(3):268-73. PubMed ID: 19109953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-dystrophic 129 REJ mice are susceptible to i.p. infection with Listeria monocytogenes despite an ability to recruit inflammatory neutrophils to the peritoneal cavity.
    Gahan CG; Collins JK
    Microb Pathog; 1995 May; 18(5):355-64. PubMed ID: 7476100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells.
    Lucas B; Engel A; Camus D; Haque A
    Cell Immunol; 1993 Aug; 150(1):59-71. PubMed ID: 8102089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.